Analysis of risk factors and clinical prognosis of acute kidney injury early after lung transplantation
-
摘要:
目的 分析肺移植术后早期急性肾损伤(AKI)的危险因素及预后。 方法 回顾性分析155例肺移植或心肺联合移植受者的临床资料,根据2012年改善全球肾脏病预后组织指南分为AKI组(104例)及非AKI组(51例)。总结肺移植术后早期AKI发生情况;收集受者的主要指标,对肺移植术后早期发生AKI的危险因素进行单因素和多因素分析;分析肺移植受者的预后情况并绘制生存曲线。 结果 肺移植术后早期AKI的发生率为67.1%(104/155),其中AKI 1期47例,AKI 2期34例,AKI 3期23例,术后早期需要连续性肾脏替代治疗(CRRT)的受者16例。术前合并糖尿病、术前合并肺动脉高压、术中平均动脉压(MAP) < 60 mmHg、术中大量输血、术后1周内他克莫司(Tac)超治疗浓度为肺移植术后早期发生AKI的独立危险因素。截止至随访终点,共66例(42.6%)受者死亡,其中AKI组50例,非AKI组16例。AKI组累积生存率低于非AKI组(40%比66%,P < 0.05),随着AKI严重程度增加,肺移植受者累积生存率降低。 结论 肺移植术后早期AKI发生率高、预后差,术前合并糖尿病、肺动脉高压,术中MAP < 60 mmHg、大量输血和术后1周内Tac超治疗浓度为肺移植术后早期发生AKI的独立危险因素。 -
关键词:
- 肺移植 /
- 急性肾损伤(AKI) /
- 他克莫司(Tac) /
- 连续性肾脏替代治疗(CRRT) /
- 平均动脉压(MAP) /
- 血清肌酐 /
- 估算肾小球滤过率 /
- 重症监护室
Abstract:Objective To analyze the risk factors and clinical prognosis of acute kidney injury (AKI) early after lung transplantation. Methods Clinical data of 155 recipients undergoing lung transplantation or combined heart-lung transplantation were retrospectively analyzed, and they were divided into the AKI group (n=104) and non-AKI group (n=51) according to the 2012 Kidney Disease: Improving Global Outcomes Clinical Practice Guideline. The incidence of AKI early after lung transplantation was summarized. The main indexes of recipients were collected. The risk factors of the occurrence of AKI early after lung transplantation were subjected to univariate and multivariate analysis. The clinical prognosis of lung transplant recipients was evaluated and the survival curve was delineated. Results The incidence of AKI early after lung transplantation was 67.1%(104/155), including 47 recipients with stage 1 AKI, 34 recipients with stage2 AKI and 23 recipients with stage 3 AKI, respectively. Sixteen recipients required continuous renal replacement therapy (CRRT) early after lung transplantation. Preoperative complication with diabetes mellitus, preoperative complication with pulmonary hypertension, intraoperative mean arterial pressure (MAP) < 60 mmHg, intraoperative massive blood transfusion, and treatment with excessive therapeutic concentration of tacrolimus (Tac) within postoperative 1 week were the independent risk factors for the occurrence of AKI early after lung transplantation. Up to the end of follow-up, 66 recipients (42.6%) died, including 50 recipients in the AKI group and 16 recipients in the non-AKI group. The cumulative survival rate in the AKI group was significantly lower than that in the non-AKI group (40% vs. 66%, P < 0.05). With the increase of AKI severity, the cumulative survival rate of lung transplant recipients was decreased. Conclusions AKI develops early after lung transplantation with high incidence and poor clinical prognosis. Preoperative complication with diabetes mellitus and pulmonary hypertension, intraoperative MAP < 60 mmHg and massive blood transfusion, and treatment with excessive therapeutic concentration of Tac within postoperative 1 week are the independent risk factors for the occurrence of AKI early after lung transplantation. -
表 1 AKI分期标准
Table 1. Staging criteria of AKI
分期 血清肌酐 尿量 1期 48 h内上升≥0.3 mg/dL(≥26.5 μmol/L),或7 d内升至1.5~1.9倍基础值 尿量 < 0.5 mL/(kg·h),持续6~12 h 2期 7 d内升至2.0~2.9倍基础值 尿量 < 0.5 mL/(kg·h),持续 > 12 h 3期 48 h内上升至≥4 mg/dL(353.6 µmol/L),或7 d内升至 > 3倍基础值,或开始CRRT 尿量 < 0.3 mL/(kg·h),持续24 h或无尿12 h 表 2 肺移植术后早期AKI的危险因素分析
Table 2. Analysis of risk factors of AKI early after lung transplantation
变量 单因素分析 多因素分析 HR① 95%CI② P值 HR 95%CI P值 术前合并糖尿病 2.548 1.033~6.289 0.042 3.489 1.159~10.500 0.026 术前合并肺动脉高压 2.367 1.091~5.134 0.029 3.311 1.291~8.492 0.013 术前尿蛋白阳性 2.389 1.009~5.656 0.048 -③ - 0.546 术前IMV支持 4.408 1.140~14.284 0.030 - - 0.635 手术方式-单肺 参考值 - - - - 0.425 手术方式-双肺 3.187 1.486~6.836 0.003 - - 0.821 手术方式-心肺联合 1.205 0.280~5.575 0.770 - - 0.213 手术时间 1.006 1.003~1.009 < 0.001 - - 0.961 术中MAP < 60 mmHg 5.707 1.900~17.145 0.002 3.845 1.105~13.377 0.034 术中大量输血④ 1.652 1.306~2.589 < 0.001 1.578 1.299~2.026 < 0.001 术中ECMO支持 2.942 1.156~5.681 0.021 - - 0.199 术后APACHEⅡ评分高 1.102 1.038~1.171 0.002 - - 0.174 术后1周内Tac超治疗浓度 2.093 1.048~4.182 0.036 3.557 1.492~8.480 0.004 注:①HR为风险比。
②CI为可信区间。
③-为无数据。
④大量输血指手术期间输血总量超过自身血容量。 -
[1] VENUTA F, VAN RAEMDONCK D. History of lung transplantation[J]. J Thorac Dis, 2017, 9(12): 5458-5471. DOI: 10.21037/jtd.2017.11.84. [2] CHAMBERS DC, CHERIKH WS, GOLDFARB SB, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult lung and heart-lung transplant report-2018; focus theme: multiorgan transplantation[J]. J Heart Lung Transplant, 2018, 37(10): 1169-1183. DOI: 10.1016/j.healun.2018.07.020. [3] LYU DM, ZAMORA MR. Medical complications of lung transplantation[J]. Proc Am Thorac Soc, 2009, 6(1): 101-107. DOI: 10.1513/pats.200808-077GO. [4] CHAMBERS DC, YUSEN RD, CHERIKH WS, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time[J]. J Heart Lung Transplant, 2017, 36(10): 1047-1059. DOI: 10.1016/j.healun.2017.07.016. [5] LERTJITBANJONG P, THONGPRAYOON C, CHEUNGPASITPORN W, et al. Acute kidney injury after lung transplantation: a systematic review and Meta-analysis[J]. J Clin Med, 2019, 8(10): 1713. DOI: 10.3390/jcm8101713. [6] THONGPRAYOON C, LERTJITBANJONG P, HANSRIVIJIT P, et al. Acute kidney injury in patients undergoing cardiac transplantation: a Meta-analysis[J]. Medicines (Basel), 2019, 6(4): 108. DOI: 10.3390/medicines6040108. [7] KHWAJA A. KDIGO clinical practice guidelines for acute kidney injury[J]. Nephron Clin Pract, 2012, 120(4): c179-c184. DOI: 10.1159/000339789. [8] BALCI MK, VAYVADA M, SALTURK C, et al. Incidence of early acute kidney injury in lung transplant patients: a single-center experience[J]. Transplant Proc, 2017, 49(3): 593-598. DOI: 10.1016/j.transproceed.2017.01. 031. [9] FIDALGO P, AHMED M, MEYER SR, et al. Incidence and outcomes of acute kidney injury following orthotopic lung transplantation: a population-based cohort study[J]. Nephrol Dial Transplant, 2014, 29(9): 1702-1709. DOI: 10.1093/ndt/gfu226. [10] ROCHA PN, ROCHA AT, PALMER SM, et al. Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality[J]. Am J Transplant, 2005, 5(6): 1469-1476. DOI: 10.1111/j.1600-6143.2005.00867.x. [11] WEHBE E, BROCK R, BUDEV M, et al. Short-term and long-term outcomes of acute kidney injury after lung transplantation[J]. J Heart Lung Transplant, 2012, 31(3): 244-251. DOI: 10.1016/j.healun.2011.08.016. [12] THOMAS JL, PHAM H, LI Y, et al. Hypoxia-inducible factor-1α activation improves renal oxygenation and mitochondrial function in early chronic kidney disease[J]. Am J Physiol Renal Physiol, 2017, 313(2): F282-F290. DOI: 10.1152/ajprenal.00579.2016. [13] GUPTA S, TORRES F, BOLLINENI S, et al. Left ventricular dysfunction after lung transplantation for pulmonary arterial hypertension[J]. Transplant Proc, 2015, 47(9): 2732-2736. DOI: 10.1016/j.transproceed. 2015.07.040. [14] TUDORACHE I, SOMMER W, KÜHN C, et al. Lung transplantation for severe pulmonary hypertension--awake extracorporeal membrane oxygenation for postoperative left ventricular remodelling[J]. Transplantation, 2015, 99(2): 451-458. DOI: 10.1097/TP.0000000000000348. [15] NUIS RJ, RODÉS-CABAU J, SINNING JM, et al. Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation[J]. Circ Cardiovasc Interv, 2012, 5(5): 680-688. DOI: 10.1161/CIRCINTERVENTIONS.112.971291. [16] NUIS RJ, VAN MIEGHEM NM, TZIKAS A, et al. Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation[J]. Catheter Cardiovasc Interv, 2011, 77(6): 881-889. DOI: 10.1002/ccd.22874. [17] KINDZELSKI BA, CORCORAN P, SIEGENTHALER MP, et al. Postoperative acute kidney injury following intraoperative blood product transfusions during cardiac surgery[J]. Perfusion, 2018, 33(1): 62-70. DOI: 10.1177/0267659117712405. [18] BUTLER CE, DICKENS EL. Transfusion tomorrow: Royal College of Pathologists, November 2010[J]. Transfus Med, 2011, 21(4): 224-230. DOI: 10.1111/j.1365-3148.2011.01091.x. [19] SIKMA MA, HUNAULT CC, VAN DE GRAAF EA, et al. High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury[J]. Eur J Clin Pharmacol, 2017, 73(5): 573-580. DOI: 10.1007/s00228-017-2204-8. [20] MASON DP, SOLOVERA-ROZAS M, FENG J, et al. Dialysis after lung transplantation: prevalence, risk factors and outcome[J]. J Heart Lung Transplant, 2007, 26(11): 1155-1162. DOI: 10.1016/j.healun.2007.08.006. [21] BARRACLOUGH K, MENAHEM SA, BAILEY M, et al. Predictors of decline in renal function after lung transplantation[J]. J Heart Lung Transplant, 2006, 25(12): 1431-1435. DOI: 10.1016/j.healun.2006.09.023. [22] ESPOSITO C, DE MAURI A, VITULO P, et al. Risk factors for chronic renal dysfunction in lung transplant recipients[J]. Transplantation, 2007, 84(12): 1701-1703. DOI: 10.1097/01.tp.0000295989.63674.53. [23] ISSA N, KUKLA A, IBRAHIM HN. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence[J]. Am J Nephrol, 2013, 37(6): 602-612. DOI: 10.1159/000351648. [24] BENNETT D, FOSSI A, MARCHETTI L, et al. Postoperative acute kidney injury in lung transplant recipients[J]. Interact Cardiovasc Thorac Surg, 2019, 28(6): 929-935. DOI: 10.1093/icvts/ivy355. [25] JACQUES F, EL-HAMAMSY I, FORTIER A, et al. Acute renal failure following lung transplantation: risk factors, mortality, and long-term consequences[J]. Eur J Cardiothorac Surg, 2012, 41(1): 193-199. DOI: 10.1016/j.ejcts.2011.04.034. [26] ATCHADE E, BAROUR S, TRAN-DINH A, et al. Acute kidney injury after lung transplantation: perioperative risk factors and outcome[J]. Transplant Proc, 2020, 52(3): 967-976. DOI: 10.1016/j.transproceed.2020.01.018.